Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Prednisone Taper vs Placebo in MS Relapses
NCT01411514Phase 4Terminated
- Sponsor
- Gobbi Novag
- Start
- Aug 2011
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in multiple sclerosis (MS), sponsored by Gobbi Novag. Started Aug 2011; status: terminated.
02
Drugs
prednisone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01411514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411514.